Patents by Inventor Ralph P. Stone

Ralph P. Stone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OPHTHALMIC FORMULATIONS AND RELATED METHODS
    Publication number: 20240315960
    Abstract: This disclosure is directed to ophthalmic suspensions for dry eye and other ocular indications that provide long-lasting on eye benefits. The disclosure provides methods of increasing lipid layer thickness and methods of lubricating an eye. The disclosure also provides methods of maintaining integrity of an eye's tear film layers which increases the eye's lipid layer thickness and methods of recreating or building one or more layers of an eye's tear film.
    Type: Application
    Filed: June 3, 2024
    Publication date: September 26, 2024
    Inventors: Timothy R. WILLIS, Ralph P. STONE
  • Ophthalmic formulations and related methods
    Patent number: 12005139
    Abstract: This disclosure is directed to ophthalmic suspensions for dry eye and other ocular indications that provide long-lasting on eye benefits. The disclosure provides methods of increasing lipid layer thickness and methods of lubricating an eye. The disclosure also provides methods of maintaining integrity of an eye's tear film layers which increases the eye's lipid layer thickness and methods of recreating or building one or more layers of an eye's tear film.
    Type: Grant
    Filed: June 8, 2023
    Date of Patent: June 11, 2024
    Assignee: ETERNATEAR, INC.
    Inventors: Timothy R Willis, Ralph P. Stone
  • Ophthalmic formulations and related methods
    Patent number: 11964047
    Abstract: This disclosure is directed to ophthalmic suspensions for dry eye and other ocular indications that provide long-lasting on eye benefits. The disclosure provides methods of increasing lipid layer thickness and methods of lubricating an eye. The disclosure also provides methods of maintaining integrity of an eye's tear film layers which increases the eye's lipid layer thickness and methods of recreating or building one or more layers of an eye's tear film.
    Type: Grant
    Filed: June 8, 2023
    Date of Patent: April 23, 2024
    Assignee: ETERNATEAR, INC.
    Inventors: Timothy R. Willis, Ralph P. Stone
  • Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery
    Patent number: 11957702
    Abstract: This disclosure is directed to ophthalmic suspension vehicles for delivery of at least one pharmaceutical ingredient to a patient in need of treatment. The disclosure also provides methods of delivering at least one pharmaceutical ingredient to a patient in need of treatment.
    Type: Grant
    Filed: August 28, 2023
    Date of Patent: April 16, 2024
    Inventors: Timothy R Willis, Ralph P. Stone
  • OPHTHALMIC SUSPENSION VEHICLES AND RELATED METHODS FOR PHARMACEUTICAL INGREDIENT DELIVERY
    Publication number: 20230414646
    Abstract: This disclosure is directed to ophthalmic suspension vehicles for delivery of at least one pharmaceutical ingredient to a patient in need of treatment. The disclosure also provides methods of delivering at least one pharmaceutical ingredient to a patient in need of treatment.
    Type: Application
    Filed: August 28, 2023
    Publication date: December 28, 2023
    Inventors: Timothy R. WIllis, Ralph P. Stone
  • OPHTHALMIC FORMULATIONS AND RELATED METHODS
    Publication number: 20230320980
    Abstract: This disclosure is directed to ophthalmic suspensions for dry eye and other ocular indications that provide long-lasting on eye benefits. The disclosure provides methods of increasing lipid layer thickness and methods of lubricating an eye. The disclosure also provides methods of maintaining integrity of an eye's tear film layers which increases the eye's lipid layer thickness and methods of recreating or building one or more layers of an eye's tear film.
    Type: Application
    Filed: June 8, 2023
    Publication date: October 12, 2023
    Inventors: Timothy R. WILLIS, Ralph P. Stone
  • OPHTHALMIC FORMULATIONS AND RELATED METHODS
    Publication number: 20230310312
    Abstract: This disclosure is directed to ophthalmic suspensions for dry eye and other ocular indications that provide long-lasting on eye benefits. The disclosure provides methods of increasing lipid layer thickness and methods of lubricating an eye. The disclosure also provides methods of maintaining integrity of an eye's tear film layers which increases the eye's lipid layer thickness and methods of recreating or building one or more layers of an eye's tear film.
    Type: Application
    Filed: June 8, 2023
    Publication date: October 5, 2023
    Inventors: Timothy R. Willis, Ralph P. Stone
  • Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery
    Patent number: 11771714
    Abstract: This disclosure is directed to ophthalmic suspension vehicles for delivery of at least one pharmaceutical ingredient to a patient in need of treatment. The disclosure also provides methods of delivering at least one pharmaceutical ingredient to a patient in need of treatment.
    Type: Grant
    Filed: June 30, 2022
    Date of Patent: October 3, 2023
    Inventors: Ralph P. Stone, Timothy R. Willis
  • OPHTHALMIC SUSPENSION VEHICLES AND RELATED METHODS FOR PHARMACEUTICAL INGREDIENT DELIVERY
    Publication number: 20230285436
    Abstract: This disclosure is directed to ophthalmic suspension vehicles for delivery of at least one pharmaceutical ingredient to a patient in need of treatment. The disclosure also provides methods of delivering at least one pharmaceutical ingredient to a patient in need of treatment.
    Type: Application
    Filed: June 30, 2022
    Publication date: September 14, 2023
    Inventors: Ralph P. Stone, Timothy R. WILLIS
  • OPHTHALMIC SUSPENSION VEHICLES AND RELATED METHODS FOR PHARMACEUTICAL INGREDIENT DELIVERY
    Publication number: 20230285437
    Abstract: This disclosure is directed to ophthalmic suspension vehicles for delivery of at least one pharmaceutical ingredient to a patient in need of treatment. The disclosure also provides methods of delivering at least one pharmaceutical ingredient to a patient in need of treatment.
    Type: Application
    Filed: September 7, 2022
    Publication date: September 14, 2023
    Inventors: Timothy R. WILLIS, Ralph P. STONE
  • Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery
    Patent number: 11752167
    Abstract: This disclosure is directed to ophthalmic suspension vehicles for delivery of at least one pharmaceutical ingredient to a patient in need of treatment. The disclosure also provides methods of delivering at least one pharmaceutical ingredient to a patient in need of treatment.
    Type: Grant
    Filed: September 7, 2022
    Date of Patent: September 12, 2023
    Inventors: Timothy R. Willis, Ralph P Stone
  • Ophthalmic formulations and related methods
    Patent number: 11679078
    Abstract: This disclosure is directed to ophthalmic suspensions for dry eye and other ocular indications that provide long-lasting on eye benefits. The disclosure provides methods of increasing lipid layer thickness and methods of lubricating an eye. The disclosure also provides methods of maintaining integrity of an eye's tear film layers which increases the eye's lipid layer thickness and methods of recreating or building one or more layers of an eye's tear film.
    Type: Grant
    Filed: March 8, 2022
    Date of Patent: June 20, 2023
    Assignee: ETERNATEAR, INC.
    Inventors: Ralph P. Stone, Timothy R. Willis
  • Ophthalmic formulations and related methods
    Patent number: 11679079
    Abstract: This disclosure is directed to ophthalmic suspensions for dry eye and other ocular indications that provide long-lasting on eye benefits. The disclosure provides methods of increasing lipid layer thickness and methods of lubricating an eye. The disclosure also provides methods of maintaining integrity of an eye's tear film layers which increases the eye's lipid layer thickness and methods of recreating or building one or more layers of an eye's tear film.
    Type: Grant
    Filed: August 25, 2022
    Date of Patent: June 20, 2023
    Assignee: ETERNATEAR, INC.
    Inventors: Timothy R. Willis, Ralph P. Stone
  • Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery
    Patent number: 11471475
    Abstract: This disclosure is directed to ophthalmic suspension vehicles for delivery of at least one pharmaceutical ingredient to a patient in need of treatment. The disclosure also provides methods of delivering at least one pharmaceutical ingredient to a patient in need of treatment.
    Type: Grant
    Filed: March 8, 2022
    Date of Patent: October 18, 2022
    Inventors: Ralph P. Stone, Timothy R. Willis
  • Ophthalmic formulations providing durable ocular lubrication
    Patent number: 11278493
    Abstract: This disclosure is directed to an ophthalmic formulation for dry eye and other ocular indications that provides long-lasting benefits. The formulations described herein provide durable relief and last two to ten longer on the eye than currently marketed products. The disclosure also provides methods of alleviating the symptoms of dry eye, methods for delivering ophthalmic pharmaceuticals, and methods of manufacture of the long-lasting ophthalmic formulations.
    Type: Grant
    Filed: December 9, 2019
    Date of Patent: March 22, 2022
    Assignee: ETERNATEAR, INC.
    Inventors: Timothy R. Willis, Ralph P. Stone
  • OPHTHALMIC FORMULATIONS PROVIDING DURABLE OCULAR LUBRICATION
    Publication number: 20210386671
    Abstract: This disclosure is directed to an ophthalmic formulation for dry eye and other ocular indications that provides long-lasting benefits. The formulations described herein provide durable relief and last two to ten longer on the eye than currently marketed products. The disclosure also provides methods of alleviating the symptoms of dry eye, methods for delivering ophthalmic pharmaceuticals, and methods of manufacture of the long-lasting ophthalmic formulations.
    Type: Application
    Filed: August 12, 2021
    Publication date: December 16, 2021
    Applicant: EternaTear, Inc.
    Inventors: Timothy R. Willis, Ralph P. Stone
  • OPHTHALMIC FORMULATIONS PROVIDING DURABLE OCULAR LUBRICATION
    Publication number: 20200179281
    Abstract: This disclosure is directed to an ophthalmic formulation for dry eye and other ocular indications that provides long-lasting benefits. The formulations described herein provide durable relief and last two to ten longer on the eye than currently marketed products. The disclosure also provides methods of alleviating the symptoms of dry eye, methods for delivering ophthalmic pharmaceuticals, and methods of manufacture of the long-lasting ophthalmic formulations.
    Type: Application
    Filed: December 9, 2019
    Publication date: June 11, 2020
    Inventors: Timothy R. Willis, Ralph P. Stone
  • Scleral lens solution
    Patent number: 9259437
    Abstract: A scleral lens solution comprising an aqueous mixture that includes sodium, potassium, calcium and magnesium cations and a pH in a range from about 6.5 to about 8.7.
    Type: Grant
    Filed: May 22, 2014
    Date of Patent: February 16, 2016
    Assignee: SMM Ventures, LLC
    Inventor: Ralph P Stone
  • SCLERAL LENS SOLUTION
    Publication number: 20140348956
    Abstract: A scleral lens solution comprising an aqueous mixture that includes sodium, potassium, calcium and magnesium cations and a pH in a range from about 6.5 to about 8.7.
    Type: Application
    Filed: May 22, 2014
    Publication date: November 27, 2014
    Inventor: Ralph P. Stone
  • Use of ocular vitamins in conjunction with other treatment methods for AMD
    Publication number: 20040258769
    Abstract: The present invention is directed to methods for enhancing current treatment regimens for age-related macular degeneration (AMD). The methods of the invention include intraocular delivery of AMD compositions along with antioxidant compositions. Alternatively, the methods of the invention include a daily regimen of ocular vitamin consumption in conjunction with other treatment methods for AMD.
    Type: Application
    Filed: June 18, 2004
    Publication date: December 23, 2004
    Inventors: Ronnie C. Barker, John C. Lang, Ralph P. Stone